<analysis>
**Action 1 (annex to regulators, then the abstract).** This action bundles four deliverables with different risk.
- **DFS production (15 October):** compelled by a regulator. The ~31,000-document e-discovery is heavy, but a regulator's deadline is almost always met, even if partly. Low risk.
- **AI Office annex:** counsel has held it through three straight months of *Buist*.
- **Voluntary CAISI and UK AISI offers:** these are exactly the selective-waiver exposure counsel fears.
- **20 October abstract:** IR and the chair's office blocked a similar RSO post on 5 August.

The discovery-scope risk is modelled in Threat 1, so I do not add it here. What remains is execution risk: finishing counsel's review of a ~140-page annex, and IR friction over the abstract. Sharing it with the Trust does not bind anyone.

**Action 2 (open-weights probe arms).** Counsel cleared the open-weight fork runs in July, and the bar covers only the Mythos family.
- **Engineering:** the Qwen 5.5 MoE layer-sweep fix and the shuffled-label controls slipped in September.
- **Counsel:** a protective order touching "evaluation-awareness analyses" could make counsel nervous even about open-weight results.
- **The result itself:** whether the result collapses is not execution risk. It sits in Threat 2.

**Action 3 (custodian readiness).** Mostly routine continuation.
- The vendor-specific auditor updates depend on published credential lifecycles, which are thin, so partial delivery is likely.
- The six pending accounts need their security teams' reviews to finish.
- Hunting-query validation historically passes at about 50%.

**Action 4 (archive, narrow scope).** Software Heritage and the Internet Archive need no partner approval. The EleutherAI mirror needs a real agreement and a checksum manifest. Counsel may still dispute the probe code and results if the protective order bites. Moderate risk.

**Action 5 (successor oversight).**
- The Trust meeting is already requested, so it is likely to happen.
- The monthly sampling-statistics post faces IR friction.
- The METR offer is likely declined; Threat 4 carries that.
- The pre-stated response to a named class is conditional and probably will not trigger this month.

**Declared internal and exogenous distributions (resolved by stated roll-substitutes, not judgement):**
- **GPT-7 agent general availability in October:** 70%. Occurs if Action 1's roll plus Threat 1's roll, mod 100, is below 70.
- **Gemini 5 Deep release in October:** 45%. Occurs if Action 2's roll plus Threat 3's roll, mod 100, is below 45.
- **Successor over October (~370 more merges plus 100% sampling on the flagged settings).** Resolved by Action 5's roll plus Threat 5's roll, mod 100:

| Outcome | Probability | Bin |
|---|---|---|
| Automatic halt | 15% | 00–14 |
| Sampling anomaly that needs review | 20% | 15–34 |
| Clean | 65% | 35–99 |

- **AI Office follow-up on the missing annex:** 55%, since it will press if the annex misses 10 October. Resolved by Action 4's roll, mod 100 below 55.
- **Trust public statement after the meeting:** 20%, by Threat 4's roll below 20.
- The review aid stays at 20% capability. Any coverage claim must be consistent with that.
</analysis>

<action_odds>
Action 1 [annex to regulators and 20 October abstract]: P(failure) 40%. Reason: DFS is compelled and near-certain, but the AI Office and voluntary sends and the abstract face three months of counsel holds and IR's precedent of blocking RSO posts. Discovery-scope risk is left to Threat 1.

Action 2 [open-weights probe arms published]: P(failure) 35%. Reason: the MoE sweep and controls slipped last month; counsel may extend caution to any eval-awareness publication under a protective order. The prior clearance for open-weight runs helps.

Action 3 [custodian readiness for GPT-7 and Gemini]: P(failure) 25%. Reason: routine established channels. Vendor-specific auditor updates depend on thin public documentation, and query validation passes only about half the time.

Action 4 [archive on undisputed scope]: P(failure) 30%. Reason: narrowing the scope and using no-approval depositories remove most blockers. The EleutherAI mirror timing and possible counsel objection to probe material remain.

Action 5 [verifiable successor oversight]: P(failure) 30%. Reason: the Trust meeting is already requested. The monthly statistics post is exposed to IR and board friction. METR's reply is carried by Threat 4.
</action_odds>

<threat_odds>
Threat 1 [*Buist* turns annex into litigation exhibit]: P(materialises) 35%. Adversary suggested 40%. The restart is likely added to discovery, but the magistrate setting a protective-order schedule that explicitly covers eval-awareness root causes this month is less certain. The compelled DFS path survives either way. If it materialises, the abstract is also blocked in about 1 of 4 cases, resolved by the lower quarter of the roll band (00–08).

Threat 2 [format-matched rerun collapses and is used against the programme]: P(materialises) 35%. Adversary suggested 45%. The forks' ±0.03 clustering and the known prompt-format sensitivity make a collapse plausible. However, spreads of 0.63–0.71 AUROC across lineages often partly survive controls, and "used against" needs a result to be published, from Anthropic or EleutherAI.

Threat 3 [first external long-horizon agent incident disclosed]: P(materialises) 25%. Adversary suggested 30%. More than 5,000 multi-month deployments run without persistence detection, plus possible GPT-7 general availability, give a real hazard. However, a public disclosure within a single month is less likely than an occurrence. The supply-chain designation is credible friction for CISA's standby and will be reconciled.

Threat 4 [METR declines the resources and the class slips past October]: P(materialises) 55%. Adversary suggested 50%. "Late October at earliest" already implies likely slippage. Independence optics make declining Anthropic compute very likely, and staff are stretched by the GPT-7 and Gemini evaluations.

Threat 5 [push to relax oversight or expand Extended]: P(materialises) 30%. Adversary suggested 35%. Rival releases and a stock about 50% down create pressure, and the board has overridden the RSO before. However, the committee adopted (b) only a month ago, 575 clean merges argue for leaving it alone, and the Trust meeting and DFS scrutiny raise the cost. If it materialises, it passes in some form in half of cases (roll 00–14).
</threat_odds>
